About Us
Services
Pharmacovigilance
ICSR Case Processing
Literature Search
Aggregate Reporting
Signal Management
Risk Management
QPPV
PSMF
Medical Information
Regulatory Affairs
Medical Writing
Medical Affairs
Specialty Areas
ATMPs
Medical Devices
Insights
Brochures
Case Studies
Videos
Articles
Whitepapers
Blogs
Webinar Recordings
Infographics
News & Events
Careers
Contact Us
Home
August 8, 2022
August 8, 2022
Designing a Safety and Risk Management System for Cellular Therapies
April 5, 2021
April 5, 2021
Regulatory considerations for cellular and gene therapy products in EU and US: A comparative analysis
March 9, 2021
March 9, 2021
Classification of cellular therapy and gene therapy (CGT) products: How regulators are working with industry
March 8, 2021
March 8, 2021
End-to-end pharmacovigilance support for a UK-based pharmaceutical company
APCER’s Pharmacovigilance (PV) team supported a client’s expansion into new markets by setting up a
…
March 8, 2021
March 8, 2021
Setting up Agile PV operations for a US based Pharma company
APCER’s Pharmacovigilance (PV) team helped a biotech pharmaceutical company with set up, training and database
…
March 8, 2021
March 8, 2021
Enabling global expansion by establishing an integrated PV system
APCER helped a global pharmaceutical company in establishing a collaborative global pharmacovigilance (PV) governance model;
…
January 12, 2021
January 12, 2021
Importance of Engaging a Safety Partner Early in the Drug Life Cycle
Ms. Jeanne Schow, Vice President & US Head of Business Development talks the key benefits
…
January 10, 2021
January 10, 2021
Virtual Auditing Services
Our team of experienced auditors help the bio-pharma companies achieve process excellence and regulatory compliance.
…
January 6, 2021
January 6, 2021
APCER Factsheet
Snapshot of end-to-end Safety services offered by APCER Life Sciences. We provide comprehensive drug safety/pharmacovigilance,
…
December 24, 2020
December 24, 2020
Need for successful launch of Mass Vaccination: Is the world ready?
December 11, 2020
December 11, 2020
Advanced Therapy Medicinal Products – The Next Therapeutic Revolution
Dr. Vineet Kacker, Managing Director & Global Technical Head talks about the how Advanced Therapy
…
November 5, 2020
November 5, 2020
Human medicinal products containing nitrosamine impurities: Regulatory landscape in the United States and the European Union
Have any questions?
(+1) 609 455 1600
info@apcerls.com